Jiradej Manosroi

Title: Jiradej Manosroi: Revolutionizing Protein Production in Thrombolysis

Introduction:

Jiradej Manosroi, a talented innovator from Chiang Mai, Thailand, has made significant contributions to the field of innovation, particularly in protein production and thrombolysis. With several patents to his name and a dynamic career at Boehringer Ingelheim International GmbH, Jiradej Manosroi's work exemplifies excellence and dedication to pushing the boundaries of scientific advancement.

Latest Patents:

1. Methods for large scale production of recombinant DNA-derived tPA or K2S molecules:

Jiradej Manosroi's groundbreaking invention in this patent is focused on producing recombinant DNA-derived tissue plasminogen activator (tPA) or Kringle 2 Serine (K2S) molecules in prokaryotic cells. The method ensures the production of active and correctly folded proteins, which are secreted extracellularly. Additionally, the patent explores the use of specific K2S derivatives derived from this method.

2. Methods for large scale protein production in prokaryotes:

In this patent, Jiradej Manosroi revolutionizes protein production in prokaryotic cells, enabling the secretion of active and correctly folded heterologous proteins. The method utilizes a vector containing the DNA coding for the protein of interest operably linked to the signal peptide OmpA.

Career Highlights:

Throughout his career, Jiradej Manosroi has achieved remarkable milestones. His dedication to the field of thrombolysis and protein production has garnered recognition, including the development of novel methods that enhance large-scale production capabilities. Jiradej's patents reflect his deep understanding of the intricate mechanisms involved in protein synthesis and his commitment to advancing the therapeutic potential of thrombolysis.

Collaborations:

Jiradej Manosroi has had the privilege of collaborating with notable researchers and innovators in his field. Among his coworkers at Boehringer Ingelheim International GmbH, Aranya Manosroi and Chatchai Tayapiwatana have contributed to research projects and shared their expertise on protein production. Together, they form a formidable team, driving innovation in the field of thrombolysis.

Conclusion:

Jiradej Manosroi's groundbreaking patents and highly regarded career at Boehringer Ingelheim International GmbH highlight his exceptional contributions to the field of innovation. By advancing large-scale protein production methods and exploring novel avenues in thrombolysis, Jiradej has propelled the field forward. His collaborations with esteemed colleagues demonstrate the cooperative efforts required to revolutionize scientific research and development. Jiradej Manosroi's dedication and ingenuity continue to inspire new discoveries and drive progress in the realm of innovations and patents.